NCM · Medical - Diagnostics & Research

NDRA (NDRA) Stock

$4.33 -2.70% NCM: NDRA Healthcare

Valuation

MetricValue
Price$4.33
Market Cap$3.26M
P/E Ratio-0.54
P/B Ratio3.01
P/S Ratio0.00
EPS (TTM)$-8.93
52-Week High$11.96
52-Week Low$2.96
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-350.00%
ROA-175.00%
ROCE-300.00%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.26
Current Ratio1.00

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-11.0M$-13.0M$-11.0M$-11.0M$-6.0M
Net Profit$-11.0M$-13.0M$-10.0M$-12.0M$-7.0M
EPS$-5.47$-6.84$-5.89$-10.25$-8.93
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$13.0M$9.0M$7.0M$4.0M$4.0M
Total Liabilities$2.0M$2.0M$1.0M$2.0M$2.0M
Cash$9.0M$5.0M$3.0M$3.0M$1.0M
Borrowings$1.0M$1.0M$0$1.0M$0

Latest News

ASP Isotopes Maps Noble Africa Listing as Helium Project Nears Production MarketBeat · Jul 21, 2026 Join the Live Investor Webinar for Noble Africa, the Proposed ASP Isotopes Spin-Out Creating a Public Helium Company Business Wire · Jul 17, 2026 ENDRA Life Sciences Gains Compliance With Nasdaq Listings Rule MT Newswires · Jul 9, 2026 Top Midday Decliners MT Newswires · Jun 25, 2026 ASP Isotopes To Merge Noble Africa With A Unit Of ENDRA – A Look At The Key Contours Of The Deal Stocktwits · Jun 25, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-11.0M$-13.0M$-10.0M$-7.0M$-5.0M
Investing Cash Flow$0$0$0$0$-3.0M
Financing Cash Flow$3.0M$0$1.0M$0$0
Net Cash Flow$2.0M$-5.0M$-2.0M$0$-2.0M
Free Cash Flow$-11.0M$-13.0M$-10.0M$-7.0M$-5.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-196.70%
Quick Ratio0.64
Interest Coverage—
Return 1Y-30.48%
Return 3Y-99.76%
Return 5Y-99.99%

Ownership

Insiders Held8.73%
Institutions Held9.66%
Institutions Float Held10.59%
Institutional HolderSharesReport Date
Altium Capital Management, LLC51,9002026-03-31
Geode Capital Management, LLC21,0782026-03-31
Vanguard Fiduciary Trust Co10,1212026-03-31
Morgan Stanley3,5462026-03-31
Vanguard Capital Management LLC2,8162026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BBLG $1.02 -4.21% -1.10 $1.84M 0.00%
BGMS $0.91 +3.73% 0.17 $1.99M 0.00%
BNBX $0.16 +0.00% 0.00 $210492 0.00%
DHAIDIH Holding US, Inc. $0.02 +0.00% 0.00 $41853 0.00%
GCTKGlucoTrack, Inc. $0.29 +0.03% -0.05 $165300 0.00%

About NDRA

NDRA is led by CEO Alexander Y. Tokman, employs 21 people, headquartered in US, publicly traded since 2017.

NDRA stock trades at $4.33 with a market capitalization of $3.26M. The stock is valued at a price-to-earnings (P/E) ratio of -0.54, price-to-book of 3.01, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $2.96 and $11.96, and currently trades 63.8% below its 52-week high.

On profitability, NDRA generates a return on equity (ROE) of -350.00%, return on capital employed of -300.00%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides